Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPC-167832 in Combination With Delamanid and Bedaquiline in Drug-susceptible Pulmonary Tuberculosis
NCT05221502Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Apr 2022
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of quabodepistat in pulmonary tuberculosis (TB), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Apr 2022; status: completed.
02
Drugs
quabodepistat
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT05221502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05221502.